Thoratec (THOR) shares look to benefit after new data says that patients implanted with a...

|About: Thoratec Corporation (THOR)|By:, SA News Editor

Thoratec (THOR) shares look to benefit after new data says that patients implanted with a mechanical heart assistance device by rival HeartWare (HTWR) have an unexpectedly high 9.2% chance of developing a potentially life-threatening blood clot per year. THOR +14.5%, HTWR -16.5% premarket.